 Connection
Ernesto Sparrelid to Predictive Value of Tests
This is a "connection" page, showing publications Ernesto Sparrelid has written about Predictive Value of Tests.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.112 |
|
|
|
-
Aaquist T, Henriksen TV, Mariager Jakobsen LL, Fristrup CW, Pfeiffer P, de Stricker K, Sparrelid E, Moro CF, Mortensen F, Knudsen AR, Hamilton-Dutoit S, Kleeff J, Mortensen MB, Andersen CL, Detlefsen S. Circulating tumour DNA as a prognostic tool for surgically treated pancreatic ductal adenocarcinoma. Hum Pathol. 2026 Feb; 168:106024.
Score: 0.039
-
Reese T, Gilg S, Erdmann J, Jonas E, Oldhafer KJ, Sparrelid E. Future liver remnant volumetry: an E-AHPBA international survey of current practice among liver surgeons. HPB (Oxford). 2025 Jun; 27(6):861-868.
Score: 0.037
-
Coppola A, La Vaccara V, Farolfi T, Asbun HJ, Boggi U, Conlon K, Edwin B, Ferrone C, Jonas E, Kokudo N, Perez EM, Satoi S, Sparrelid E, Stauffer J, Zerbi A, Takemura N, Lai Q, Almerey T, Bernon M, Cammarata R, Djoumi Y, Gallagher T, Ghorbani P, Ginesini M, Hashimoto D, Kauffmann EF, Kleive D, Lluís N, González RM, Napoli N, Nappo G, Nebbia M, Ricchitelli S, Sahakyan MA, Yamamoto T, Coppola R, Caputo D. Preoperative carbohydrate antigen 19.9 level predicts lymph node metastasis in resectable adenocarcinoma of the head of the pancreas: a further plea for biological resectability criteria. Int J Surg. 2024 Oct 01; 110(10):6092-6099.
Score: 0.036
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|